Health Care · Services-Medical Laboratories

RDNT RadNet, Inc. SEC Filings & Insider Trading Activity 2026

company
CIK 790526121 filings
Russell 2000

RDNT at a glance

RadNet, Inc. (RDNT, SEC CIK 790526) filed its latest 10-K annual report on March 2, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 9, 2026 and Form 4 insider filings as recently as November 12, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), RadNet, Inc. (RDNT) reported revenue of $2.0 billion (up 11.5% from FY2024) and a net loss of $18.7 million. Diluted EPS was -$0.25.
  • As of September 30, 2026, 31 institutional investment managers tracked by SignalX reported holding RadNet, Inc. (RDNT) shares worth $2.5 billion in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Patel Mital on November 11, 2026 of 44,661 shares at $78.51 per share.
  • In the last 90 days, RDNT insiders reported 0 open-market purchases ($0) and 1 open-market sale ($3.5M) on Form 4, a net sale of $3.5M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$2.0B
+11.5% vs prior year
Insiders · 90 days
0 buys · 1 sell
Net −$3.5M
13F holders
31 funds
$2.5B · −1 vs prior quarter
Latest 8-K
Nov 9, 2026
Item 2.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Business Overview

  • Core business model: Diagnostic imaging services revenue from patients and third-party payors under fee-for-service and capitation contracts
  • Emphasis on capitation arrangements earning per-enrollee monthly revenue for making imaging services available to health plan members
  • Business combination accounting impacting goodwill and asset valuations with possible adjustments up to one year post-acquisition
  • Accounts receivable primarily from insurance and government programs, with continuous monitoring and allowances for credit losses
  • No introduction of new products or segments but focus on contractual revenue estimation and collection practices

Risk Factors

  • CMS 2026 Physician Fee Schedule final rule may reduce Medicare reimbursement rates and imaging volumes starting CY 2026
  • Significant exposure to California natural disasters: headquarters and 100+ centers vulnerable to wildfires, blackouts, earthquakes
  • Dependence on contracted radiology groups for managed care contracts; termination risks revenue loss and competitive position
  • Competition from private equity-backed chains and hospitals, risking market share due to their greater financial resources and newer equipment
  • Majority of indebtedness at variable rates; rising interest rates increase borrowing costs and may reduce profitability

Management Discussion & Analysis

  • Revenue $2.04B in 2025, up 11.5% YoY from $1.83B in 2024; Imaging Center revenue $1.99B up 10.9% YoY
  • Operating margin 3.0% in 2025 vs 5.7% in 2024; net income margin 0.8% in 2025 vs 2.0% in 2024
  • Best performing segment: Imaging Center $1.99B revenue (+$196M, +10.9% YoY); worst: Digital Health $92.7M revenue (+$27M, +41.0% YoY) but smaller scale
  • Operating expenses rose 13.2% to $1.89B in 2025 driven by volume growth, wages, and medical supplies; stock comp increased 66.3% to $44.7M
  • Capital allocation: acquisitions totaled $229.8M in 2025 (iCAD $110.7M, CIMAR $37M, See-Mode $28.9M), no data on buybacks/dividends disclosed
  • Management highlights expansion in Digital Health via AI acquisitions; identifies risks from wage inflation, supply costs, and weather impacting Q1 volumes

AI summary of the RDNT 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Management Discussion & Analysis

  • Revenue $638.3M, up 22.1% YoY from $522.9M, driven by Imaging Centers revenue of $617.0M
  • Segment profit $83.8M vs $69.7M YoY, with Imaging Centers $96.9M vs $74.0M and Digital Health loss $13.1M vs $4.3M
  • Best performer: Digital Health Clinical AI revenue up 50.9%; worst: Digital Health net loss $16.1M vs $7.5M
  • Cash $750.6M vs $767.2M at December 31, 2025; operating cash flow $263.6M vs $214.7M
  • Investing used $487.6M, including $249.2M higher acquisition spending; near-term Digital Health losses expected during integration and growth investment

Risk Factors

  • Newly added merger risk: ONRAD acquisition announced October 26, 2026, subject to regulatory approvals and closing conditions
  • Regulatory risk: Required clearances could significantly delay or prevent merger completion
  • Legal risk: Merger-related shareholder litigation could impose substantial costs or enjoin closing
  • Operational risk: Business partners may renegotiate or pursue alternatives amid merger uncertainty
  • Financial risk: Non-recurring advisory, integration, facilities, and systems costs may exceed expectations

AI summary of the RDNT 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 9, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • RadNet reported third-quarter fiscal 2026 financial results for the period ended September 30, 2026
  • Full operating metrics and management commentary are contained in Exhibit 99.1, the accompanying earnings release

Item EX-99.1: Item EX-99.1

  • Q3 revenue rose 22.1% to $638.3M and Adjusted EBITDA 23.8% to $105.0M, supporting stronger operating momentum
  • Adjusted diluted EPS increased to $0.30 from $0.24, while GAAP diluted EPS declined to $0.05 from $0.07
Filed Oct 26, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Acquisition of ONRAD expands RadNet into hospital-based teleradiology and professional staffing, creating a third Radiology Professional Services segment
  • First-year contribution target: $190M-$200M revenue and $60M-$65M Adjusted EBITDA, implying a capital-light, high-margin growth platform

Item 3.02: Unregistered Sales of Equity Securities

  • Item 3.02 contains no separate equity-sale details
  • Investors should review Item 1.01’s “Merger Agreement” section for the referenced transaction terms

Item 7.01: Regulation FD Disclosure

  • RadNet announced entry into a merger agreement, signaling a potentially material change in ownership or corporate structure
  • Investor webcast and conference call scheduled for October 27, 2026 at 8:00 A.M. Eastern

Item 1.01: Entry into a Material Definitive Agreement

  • RadNet to acquire OnRad, a teleradiology provider, in a transaction expected to close in early 2027
  • Consideration: $350 million cash, subject to adjustments, plus 5 million RadNet shares
Filed Aug 14, 2026Full analysis →

Item 8.01: Other Events

  • Resale registration for up to 34,069 RadNet shares issued to See-Mode sellers
  • Shares represent milestone-based consideration under the June 2, 2025 See-Mode acquisition agreement

AI summaries of RDNT 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for RDNT

Don't miss the next RDNT filing

  • Alerts as it files. A push when RDNT files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut RDNT, by share count.
  • Ask anything. An AI agent that reads every RDNT filing and answers with sources.

RDNT alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Patel MitalGNov 12, 2026-
Patel MitalSellNov 11, 2026$78.51
SWARTZ DAVID LSellJun 18, 2026$53.89
Wesdorp CornelisSellJun 16, 2026$58.11
Berger Howard GGJun 16, 2026-
Forthuber Stephen MSellJun 15, 2026$58.61
Forthuber Stephen MSellJun 15, 2026$57.79
Jacobs Laura PastreAJun 2, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue$1.6B$1.8B$2.0B
Operating Income$98.7M$104.6M$62.0M
Net Income$3.0M$2.8M-$18.7M
Op. Margin6.1%5.7%3.0%
Net Margin0.2%0.2%-0.9%
Balance Sheet
Total Assets$2.7B$3.3B$3.8B
Equity$630.7M$902.3M$1.1B
ROE0.5%0.3%-1.7%
Per Share
EPS$0.05$0.04$-0.25
Cash Flow
Operating CF-$233.0M$298.8M

Source: XBRL data in RadNet, Inc. (RDNT)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate RDNT share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
RDNT shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202631$2.52B
Q2 202632$2.21B
Q1 202633$1.94B
Q4 202530$2.46B
Q3 202530$2.44B
Q2 202529$1.72B
Q1 202526$1.04B
Q4 202423$1.29B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 234 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

RDNT filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 12, 2026--
8-KNov 9, 2026Analysis-
10-QNov 9, 2026Analysis
8-KOct 26, 2026Analysis-
8-KAug 14, 2026Analysis-
10-QAug 10, 2026Analysis
8-KAug 10, 2026Analysis-
4Jun 22, 2026--
4Jun 18, 2026--
4Jun 18, 2026--
4Jun 16, 2026--
8-KJun 10, 2026Analysis
8-KJun 4, 2026Analysis
4Jun 3, 2026-
8-KJun 3, 2026Analysis
4Jun 3, 2026-
4Jun 3, 2026-
4Jun 3, 2026-
SC 13GMay 15, 2026-
8-KMay 11, 2026Analysis
10-QMay 11, 2026Analysis
4May 6, 2026-
SC 13GApr 29, 2026-
4Mar 23, 2026--
4Mar 18, 2026--

Related Health Care companies

All Health Care →

RDNT SEC filings: frequently asked questions

Are RDNT insiders buying or selling?

In the last 90 days, RadNet, Inc. (RDNT) officers, directors and 10% owners reported no open-market purchases and 1 open-market sale worth $3.5 million by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold RDNT stock?

As of September 30, 2026, the largest RadNet, Inc. (RDNT) holders among the 13F filers tracked by SignalX were BlackRock ($759.8 million), T. Rowe Price Group ($340.7 million), Vanguard Portfolio Management LLC ($275.8 million), Vanguard Capital Management LLC ($220.2 million), State Street Corp ($199.5 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was RDNT's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), RadNet, Inc. (RDNT) reported revenue of $2.0 billion (up 11.5% from FY2024) and a net loss of $18.7 million. Diluted EPS was -$0.25. The figures come from the XBRL data in the 10-K.

What are the main risks in RDNT's latest 10-K?

In the 10-K filed March 2, 2026, RadNet, Inc. (RDNT) flagged: CMS 2026 Physician Fee Schedule final rule may reduce Medicare reimbursement rates and imaging volumes starting CY 2026. Significant exposure to California natural disasters: headquarters and 100+ centers vulnerable to wildfires, blackouts, earthquakes. (AI summary of the Risk Factors section.)

What did RDNT report in its latest 8-K?

RadNet, Inc. (RDNT) filed an 8-K on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). RadNet reported third-quarter fiscal 2026 financial results for the period ended September 30, 2026.

What are the latest RDNT SEC filings?

RadNet, Inc. (RDNT) filed its latest 10-K annual report on March 2, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 9, 2026 and a Form 4 insider filing on November 12, 2026.

What is RDNT's SEC CIK number?

RadNet, Inc. (RDNT)'s SEC Central Index Key (CIK) is 790526. EDGAR lists every RDNT filing under that number.

Ask anything about RDNT

The research agent reads RDNT's filings, financials, insider trades and 13F holders, then answers with sources.